Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain);Incidencia y prevalencia de hepatitis autoinmune en el área sanitaria del Hospital de Sagunto

Gastroenterologia y Hepatologia

Volumn 27, Issue 4, 2004, Pages 239-243

  Primo, J ^a   Merino, C ^a   Fernandez J ^a   Moles J R ^a   Llorca, P ^a   Hinojosa, J ^a  

^a HOSPITAL DE SAGUNTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; AUTOIMMUNE HEPATITIS; CONFIDENCE INTERVAL; FEMALE; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PROBABILITY; SEX DIFFERENCE; SPAIN;

EID: 2342523409     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13059351     Document Type: Article

References (16)

1. McFarlane IG. Definition and classification of autoimmune hepatitis. Semin Liver Dis 2002;22:317-24.
2. Czaja AJ, Freese DK. AASLD Practice Guidelines. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36: 479-97.
3. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
4. Álvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
5. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:347-59.
6. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99-103.
7. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
8. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. Bristol: BMJ Books, 2000.
9. Bjarnason I, Magnusson B, Björnsson S. Idiopathic chronic active hepatitis in Iceland. Acta Med Scand 1982;211:305-7.
10. Hodges JR, Millward-Sadler GH, Wright R. Chronic active hepatitis: the spectrum of disease. Lancet 1982;1:550-2.
11. Ritland S. The incidence of chronic active hepatitis in Norway. A retrospective study. Scand J Gastroenterol 1985;20(Suppl 107):58-60.
12. Olsson R, Lindberg J, Weiland O, Nilsson L. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation and laboratory profile. Scand J Gastroenterol 1988;23:463-70.
13. Tanner AR, Dellipiani AW. Chronic active hepatitis: a sixteen year survey at a district general hospital. Postgrad Med J 1989;65:725-8.
14. Nishioka M, Morshed SA, McFarlane IG. Geographical variation in the frequency and characteristics of autoimmune liver diseases. En: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases. Amsterdam: Elsevier, 1998; p. 413-24.
15. Lee YM, Teo EK, Ng TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 2001;16:1384-9.
16. Hulburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Nowdley KV. Prevalence of autoimmune liver disease in Alaska natives. Am J Gastroenterol 2002;97:2402-7.